Factory 99% Deferasirox Powder CAS 201530-41-8 Hemochromatosis Deferasirox

• Customization: Available
• Powder: Yes
• Customized: Customized
• Model NO.: A303
• Certification: GMP, HSE, ISO 9001, USP, BP
• Suitable for: Elderly, Children, Adult
• State: Powder
• Purity: >99%
• Name: Deferasirox
• CAS: 201530-41-8
• Appearance: White Powder
• Assay: 99%
• OEM: Available
• Sample: Available
• Suitable: Adult
• MOQ: 100g
• Function: Hemochromatosis
• Transport Package: Foil Bag
• Specification: 99
• Trademark: /
• Origin: China
• Production Capacity: 10000 Kgs Per Month

Product Description

Product Name	Deferasirox
Appearance	White Powder
CAS NO.	201530-41-8
Molecular Formula	C21H15N3O4
Storage	Keep in a cool, dry, dark location

 

Deferasirox is an orally active, tridentate iron chelator. It is specifically designed to bind iron with high affinity, thereby facilitating its removal from the body through excretion. This medication is primarily indicated for the treatment of chronic iron overload conditions, particularly in patients who require long-term blood transfusions due to underlying hematological disorders such as beta-thalassemia or other forms of chronic anemia. Deferasirox offers a convenient alternative to parenteral iron chelation therapy, as it can be administered orally. It is suitable for use in both pediatric patients (aged two and older) and adults, making it a versatile treatment option for a wide range of patients with iron overload.

 

 

1. Iron Overload Management: Deferasirox is primarily prescribed to manage iron overload in patients with conditions requiring frequent blood transfusions.
2. Oral Therapy: As an orally active agent, it provides a non-invasive alternative to parenteral iron chelation, enhancing patient compliance.
3. Pediatric and Adult Care: Suitable for use across different age groups, deferasirox can be tailored to meet the needs of both pediatric and adult patients.

1. Iron Binding: Deferasirox effectively binds iron, reducing its bioavailable pool and minimizing tissue damage associated with iron overload.
2. Organ Protection: By maintaining low iron levels, it helps to prevent organ damage and improve long-term health outcomes.
3. Convenient Dosing: With a half-life that allows for once-daily dosing, deferasirox enhances patient convenience and adherence to treatment.